Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes

This key economic indicator for the Healthcare sector has been recently updated.

  1. Poland was up 50% of Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes in 2019, compared to a year earlier.
  2. Since 2014 Iceland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes rose 12.4% year on year to €32 Per Capita.
  3. In 2019 Poland was ranked number 3 in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes.
  4. In 2019 Switzerland was ranked number 4 in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes totalising €0.07 Per Capita, from 6 in 2018.

Top Countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes

Euros Per Capita - 2000 to 2019

#8 CountriesEuros Per CapitaLastYoY5‑years CAGR
1 #1
Iceland
32.00 2019 +3.8 % +12.4 % View data
2 #2
Estonia
1.76 2019 -7.8 % NA View data
3 #3
Poland
0.27 2019 +50.0 % +0.8 % View data
4 #4
Portugal
0.07 2019 +0.0 % NA View data
4 #4
Switzerland
0.07 2019 +16.7 % -23.1 % View data
6 #6
Latvia
0.01 2018 -95.7 % NA View data
6 #6
Romania
0.01 2019 NA -39.2 % View data
8 #8
Croatia
0.00 2019 NA NA View data
Showing 1 to 8 of 8 countries

Source: European Commission

Go Top